Special Feature Webinar: Hormone Therapy Unlocked: Case Studies in Diagnosing and Managing Hypoactive Sexual Desire Disorder and Menopausal Hormone Therapy

August 13, 2025

After a replay of the Women’s Health Clinical Communities Speaker Series session, “Hormone Therapy Unlocked: Overcoming Barriers to Better Care,” the panelists join us live for part two, where they dissect real-world case studies on the complexities of diagnosing and managing hypoactive sexual desire disorder and menopausal symptoms in women. Meeting link: https://msteams.link/WBYJ

Wednesday, August 13, from 11:10 AM to 2:30 PM ET

Up to 1.50 live and 1.50 enduring CE/CME credits

Join on Microsoft Teams

Add to calendar

Target Audience

This activity provides continuing education for Physicians, Nurses, Pharmacists, Pharmacy Technicians, Physician Assistants/ Physician Associates, Dentists, Dental Hygienists, Dental Technicians, Social Workers, Psychologists, Registered Dieticians, Dietetic Technicians, Occupational Therapists/ Occupational Therapy Assistants, Athletic Trainers, and Kinesiotherapists. A certificate of attendance is available for other attendees.

Learning Objectives

Identify diagnostic criteria for Hypoactive Sexual Desire Disorder (HSDD) and demonstrate the ability to use validated tools like the Decreased Sexual Desire Screener to guide clinical decision-making.
Evaluate candidacy for testosterone therapy in women with HSDD by reviewing baseline labs (including total/free testosterone, sex hormone binding globule) and assessing informed consent for off-label use.
Explain the evidence, risks, and benefits of testosterone therapy in women and design a follow-up plan, including Food and Drug Administration-approved options and monitoring protocols for labs, efficacy, and side effects.
Discuss patient-centered approaches to managing HSDD, incorporating biopsychosocial elements, sexual health counseling, and shared decision-making.
Assess suitability for menopausal hormone therapy (MHT) in women with chronic disease, using a thorough history and risk stratification based on current guidelines.
Discuss the safety profile of MHT in the context of comorbidities, including cardiovascular risk, breast cancer risk, and the role of the timing hypothesis and the type of hormone used (e.g., transdermal vs oral).
Formulate an individualized MHT plan and follow-up protocol, selecting the appropriate estrogen route/dose and progestogen (if uterus is intact), while considering the symptom burden and risk profile. Review optimization and adjustments during therapy.
Recognize the clinical significance of untreated vasomotor symptoms, including the impact on sleep, quality of life, work productivity, and the association between persistent hot flashes and increased risks of cardiovascular disease, bone loss, and cognitive decline.

Course summary

Available credit:

1.50 AAPA
DHA J-7 CEPO has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 hours of AAPA Category 1 CME credits. Approval is valid until Wednesday, August 27, 2025 - 11:59pm ET. PAs should only claim credit commensurate with the extent of their participation.
1.50 ACCME Non-Physician CME Credit
DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 1.50 hours for completing this Course activity.
1.50 ACPE-Pharm
UAN: JA4008136-0000-25-079-L01-P
No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 1.50 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
1.50 ACPE-Tech
UAN: JA4008136-0000-25-079-L01-T
No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 1.50 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
1.50 ADA CERP
DHA, J-7, CEPO is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education (CDE). ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
DHA, J-7, CEPO designates this activity for 1.50 continuing education credits.
1.50 AMA PRA Category 1 Credit™
DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DHA, J-7, CEPO designated this Course for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.50 ANCC
DHA, J-7, CEPO is accredited by the Joint Accreditation/ Interprofessional Continuing Education (IPCE) to provide this Continuing Nursing Education Course for a maximum of 1.50 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
1.50 AOTA
DHA, J-7, CEPO is an American Occupational Therapy Association (AOTA) Approved Provider of professional development (PD). PD activity approval ID# PENDING. This course is offered at 0.15 CEUs, . AOTA does not endorse specific course content, products, or clinical procedures.
1.50 APA
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. Participants may earn 1.50 CE credits for completing this activity.
1.50 ASWB
As a Jointly Accredited Organization, DHA, J7, CEPO is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.50 continuing education credits.
1.50 Attendance
1.50 BOC
Board of Certification for the Athletic Trainer (BOC)
DHA, J-7, CEPO (BOC AP #: P12034) is approved by the Board of Certification, Inc., to provide continuing education to Athletic Trainers (ATs). This program is eligible for a maximum of 1.50 Category A hours/Continuing Education Units (CEUs). ATs should claim only those hours actually spent in the educational program
1.50 CDR
DHA, J-7, CEPO is a Continuing Professional Education (CPE) Accredited provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.50 Continuing Professional Education units (CPEUs) for completion of this activity/material.
1.50 COPSKT
Provider # is 081325
This continuing education activity has been accredited by The Council on Professional Standards for Kinesiotherapy (COPSKT) to include 1.50 contact hours/0.15 CEU. DHA, J-7, CEPO accredits enterprise-wide continuing education activities for military and civilian health care professionals. These courses are critical to DHA’s goal of providing the best possible quality care to active duty service members, veterans, and their families.
1.50 IPCE
In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 1.50 Interprofessional Continuing Education (IPCE) credits for learning and change.

Course opens:

06/23/2025

Course expires:

08/27/2025

Event starts:

08/13/2025 - 11:10am EDT

Event ends:

08/13/2025 - 2:30pm EDT

Add to calendar:

Presenting Faculty

Rebbecca Hertel, DO, MSCP
Family Physician, Certified Menopause Practitioner, and Founder of Osteopathic Midlife Health

Heather Quaile, DNP, WHNP-BC, AFN-C, CSC, I.F., FAANP
Scientific Committee Chair for the International Society for the Study of Women’s Sexual Health and Founder of the Sexual Health Optimization and Wellness Center

Air Force Lt. Col. Samantha Simpson, M.D.
Chief of the Reproductive Endocrinology and Infertility Division and Program Director for the SAUSHEC OB/GYN Residency Program, Brooke Army Medical Center

Retired Air Force Col. Christine Kress, DNP, APRN, WHNP-BC, NEA-BC, MSCP
Women’s Health Nurse Practitioner and Certified Menopause Practitioner, Heather Hirsch MD Collaborative

Aoife O’Sullivan, M.D., NCMP
Family Physician, Certified Menopause Practitioner, and Founder of Portland Menopause Doc

Disclosure: DHA J-7 staff, planners, faculty, and content reviewers for this educational activity have no financial or non-financial relationship(s) with ineligible companies to disclose.

Speaker(s)